Kang Sang C MD - Brooklyn, New York 11217

Kang Sang C MD is categorized under Doctors in Brooklyn, NY .

Business Name: Kang Sang C MD
Contact Person: Sang Kang
Address: 257 Flatbush Avenue, Brooklyn, New York 11217
Phone Number: (718) 789-6300
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Boro Medical Of New York Inc - Brooklyn, NY 11217
Richard J Calame Md - Brooklyn, NY 11217
Brooklyn Womens Healthcare - Brooklyn, NY 11217
Endocrine Technology LLC - Brooklyn, NY 11217
Holistic Primary Care - Brooklyn, NY 11217
Kernisant Lesly MD - Brooklyn, NY 11217
Stewart Jonathan MD - Brooklyn, NY 11217
Manter Kristen MD - Brooklyn, NY 11217
Daniel S Mundy MD - Brooklyn, NY 11217
Smerd Rachel MD - Brooklyn, NY 11217
Belkin Regina MD - Brooklyn, NY 11217
Ednalino Edgar Y MD - Brooklyn, NY 11217
Alcantara Teodorico M MD - Brooklyn, NY 11217
Alexis Georgette A MD - Brooklyn, NY 11217
Gordon Philippa Md - Brooklyn, NY 11217
Manzo Thomas J MD - Brooklyn, NY 11217
New York Mthdst Hosp-Radiology - Brooklyn, NY 11217
Douglas H Bailyn Md P C - Brooklyn, NY 11217
Philippa R Gordon MD - Brooklyn, NY 11217
Jean-Baptiste Gary E MD - Brooklyn, NY 11217

The company Kang Sang C MD provides B2C services in the form of Doctors from its single location in New York. 1 to 4 employees work for Kang Sang C MD, and the business now earns $500.000 to $999.999 per annum.

Kang Sang C MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Kang Sang C MD, please call Sang Kang with the phone number (718) 789-6300 or visit its single location at 257 Flatbush Avenue in Brooklyn, New York 11217.

The location of the single location can also be found using the coordinates 40.680111,-73.974493. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.